HEMAB THERAPEUTICS HOLDINGS (COAG) Institutional Shareholders
HEMAB THERAPEUTICS HOLDINGS (COAG) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.32B in COAG holdings during the latest filing period.
Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of COAG tracked by InsiderSet, reporting ownership valued at approximately $286.81M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $321.64M, representing an estimated gain of +12.14% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 85% of the total disclosed COAG value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Novo Holdings A/S, Fmr Llc, and several other long-term asset managers with concentrated positions in HEMAB THERAPEUTICS HOLDINGS (COAG).
This page ranks the largest institutional COAG shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
54
Total Reported Value
$1.32B
Largest Holder
Ra Capital Management, L.P.
Largest Position
$286.81M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
55
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 2.49% | 7,808,627 | $286,810,870 | $321,637,346 | +$34,826,476 | +12.14% | |
| Novo Holdings A/S | 8.92% | 4,180,550 | $153,551,602 | $172,196,855 | +$18,645,253 | +12.14% | |
| Fmr Llc | 0.01% | 3,697,837 | $135,821,553 | $152,313,906 | +$16,492,353 | +12.14% | |
| Capital International Investors | 0.03% | 3,603,876 | $132,370,365 | $148,443,652 | +$16,073,287 | +12.14% | |
| Deep Track Capital, Lp | 1.95% | 3,602,093 | $132,304,876 | $148,370,211 | +$16,065,335 | +12.14% | |
| Siren, L.L.C. | 1.56% | 2,086,834 | $76,649,413 | $85,956,692 | +$9,307,279 | +12.14% | |
| Avoro Capital Advisors Llc | 0.63% | 1,925,150 | $70,710,760 | $79,296,929 | +$8,586,169 | +12.14% | |
| Bain Capital Life Sciences Investors, Llc | 3.60% | 1,650,000 | $60,604,500 | $67,963,500 | +$7,359,000 | +12.14% | |
| Jpmorgan Chase & Co | 0.00% | 1,152,420 | $42,328,387 | $47,468,180 | +$5,139,793 | +12.14% | |
| Vanguard Capital Management Llc | 0.00% | 780,758 | $28,677,241 | $32,159,422 | +$3,482,181 | +12.14% | |
| Price T Rowe Associates Inc | 0.00% | 746,040 | $27,404,000 | $30,729,388 | +$3,325,388 | +12.13% | |
| Driehaus Capital Management Llc | 0.15% | 715,791 | $26,291,003 | $29,483,431 | +$3,192,428 | +12.14% | |
| Rock Springs Capital Management Lp | 1.03% | 575,432 | $21,135,617 | $23,702,044 | +$2,566,427 | +12.14% | |
| Bellevue Group Ag | 0.43% | 550,000 | $20,201,500 | $22,654,500 | +$2,453,000 | +12.14% | |
| Citadel Advisors Llc | 0.01% | 523,450 | $19,226,319 | $21,560,906 | +$2,334,587 | +12.14% | |
| Blackrock, Inc. | 0.00% | 283,833 | $10,425,186 | $11,691,081 | +$1,265,895 | +12.14% | |
| Deerfield Management Company, L.P. | 0.11% | 275,000 | $10,100,750 | $11,327,250 | +$1,226,500 | +12.14% | |
| Exoduspoint Capital Management, Lp | 0.07% | 218,287 | $8,017,682 | $8,991,242 | +$973,560 | +12.14% | |
| Geode Capital Management, Llc | 0.00% | 211,798 | $7,783,580 | $8,723,960 | +$940,380 | +12.08% | |
| Braidwell Lp | 0.22% | 160,000 | $5,876,800 | $6,590,400 | +$713,600 | +12.14% | |
| Marshall Wace, Llp | 0.00% | 154,674 | $5,681,176 | $6,371,022 | +$689,846 | +12.14% | |
| Woodline Partners Lp | 0.02% | 150,040 | $5,510,969 | $6,180,148 | +$669,179 | +12.14% | |
| Affinity Asset Advisors, Llc | 0.25% | 138,030 | $5,069,842 | $5,685,456 | +$615,614 | +12.14% | |
| Vanguard Fiduciary Trust Co | 0.00% | 112,499 | $4,132,088 | $4,633,834 | +$501,746 | +12.14% | |
| Charles Schwab Investment Management Inc | 0.00% | 108,236 | $3,975,508 | $4,458,241 | +$482,733 | +12.14% | |
| Ameriprise Financial Inc | 0.00% | 81,928 | $3,009,215 | $3,374,614 | +$365,399 | +12.14% | |
| Burkehill Global Management, Lp | 0.10% | 75,000 | $2,754,750 | $3,089,250 | +$334,500 | +12.14% | |
| Aberdeen Group Plc | 0.00% | 52,117 | $1,914,257 | $2,146,699 | +$232,442 | +12.14% | |
| Opaleye Management Inc. | 0.16% | 47,652 | $1,750,258 | $1,962,786 | +$212,528 | +12.14% | |
| Ubs Group Ag | 0.00% | 47,351 | $1,739,202 | $1,950,388 | +$211,186 | +12.14% | |
| Parkman Healthcare Partners Llc | 0.17% | 45,000 | $1,652,850 | $1,853,550 | +$200,700 | +12.14% | |
| Northern Trust Corp | 0.00% | 40,487 | $1,487,088 | $1,667,660 | +$180,572 | +12.14% | |
| Ghisallo Capital Management Llc | 0.03% | 40,000 | $1,469,200 | $1,647,600 | +$178,400 | +12.14% | |
| Td Asset Management Inc | 0.00% | 33,098 | $1,215,690 | $1,363,307 | +$147,617 | +12.14% | |
| Seven Grand Managers, Llc | 0.04% | 30,000 | $1,101,900 | $1,235,700 | +$133,800 | +12.14% | |
| Soros Fund Management Llc | 0.01% | 25,000 | $918,250 | $1,029,750 | +$111,500 | +12.14% | |
| Manufacturers Life Insurance Company, The | 0.00% | 18,720 | $687,586 | $771,077 | +$83,491 | +12.14% | |
| Gsa Capital Partners Llp | 0.04% | 17,661 | $649,000 | $727,457 | +$78,457 | +12.09% | |
| Xtx Topco Ltd | 0.01% | 17,389 | $638,698 | $716,253 | +$77,555 | +12.14% | |
| Landscape Capital Management, L.L.C. | 0.03% | 13,183 | $484,211 | $543,008 | +$58,797 | +12.14% | |
| Hudson Bay Capital Management Lp | 0.00% | 12,202 | $448,179 | $502,600 | +$54,421 | +12.14% | |
| Schonfeld Strategic Advisors Llc | 0.00% | 10,813 | $397,160 | $445,387 | +$48,227 | +12.14% | |
| Weiss Asset Management Lp | 0.00% | 10,000 | $367,300 | $411,900 | +$44,600 | +12.14% | |
| Vanguard Portfolio Management Llc | 0.00% | 8,169 | $300,047 | $336,481 | +$36,434 | +12.14% | |
| Vanguard Global Advisers, Llc | 0.00% | 7,616 | $279,736 | $313,703 | +$33,967 | +12.14% | |
| Squarepoint Ops Llc | 0.00% | 6,252 | $229,636 | $257,520 | +$27,884 | +12.14% | |
| Two Sigma Investments, Lp | 0.00% | 5,680 | $208,626 | $233,959 | +$25,333 | +12.14% | |
| Morgan Stanley | 0.00% | 4,078 | $149,785 | $167,973 | +$18,188 | +12.14% | |
| China Universal Asset Management Co., Ltd. | 0.01% | 3,600 | $132,228 | $148,284 | +$16,056 | +12.14% | |
| Citigroup Inc | 0.00% | 2,095 | $76,949 | $86,293 | +$9,344 | +12.14% |
Frequently asked questions about COAG
Who owns the most COAG stock?
The largest holders of COAG are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for HEMAB THERAPEUTICS HOLDINGS (COAG).
Is COAG widely held by superinvestors?
Many widely followed stocks like COAG appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly COAG is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.